# Allopurinol and Pathogenesis of Cirrhosis

> **NCT07033533** · PHASE1,PHASE2 · COMPLETED · sponsor: **Tanta University** · enrollment: 100 (actual)

## Conditions studied

- Cirrhoses, Liver

## Interventions

- **DRUG:** Allopurinol Tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07033533
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-01
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07033533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07033533, "Allopurinol and Pathogenesis of Cirrhosis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07033533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*